ALL vs OGEN · P/E 4.9, $56.89B cap vs rev $37.7K
The Allstate Corporation (ALL) versus Oragenics Inc (OGEN) — a side-by-side from cached financials, not a winner call.
The Allstate Corporation (ALL) is a insurance - property & casualty company listed on US.
Oragenics Inc (OGEN) is a biotechnology company listed on US.
ALL does not have a complete income-statement cache yet.
Latest reported OGEN revenue for 2023-12-31 was $37.7K. Net income was -$20.7M. Revenue was down 71.4% from 2022-12-31 to 2023-12-31. OGEN currently screens at market cap $2.7M.
ALL currently screens at market cap $56.89B and trailing P/E 4.9. OGEN currently screens at market cap $2.7M.
Not investment advice. Open the ALL and OGEN stock pages for the full models.
Not investment advice.